학술논문

Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of ≥300/mm3: CPCRA 059
Document Type
Article
Source
In: Journal of Acquired Immune Deficiency Syndromes. (Journal of Acquired Immune Deficiency Syndromes, 1 March 2002, 29(3):221-231)
Subject
Language
English
ISSN
15254135